WO2001058518A2 - Cardiac control using paired pacing - Google Patents
Cardiac control using paired pacing Download PDFInfo
- Publication number
- WO2001058518A2 WO2001058518A2 PCT/IL2001/000098 IL0100098W WO0158518A2 WO 2001058518 A2 WO2001058518 A2 WO 2001058518A2 IL 0100098 W IL0100098 W IL 0100098W WO 0158518 A2 WO0158518 A2 WO 0158518A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- heart
- site
- pulses
- applying
- pacing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0587—Epicardial electrode systems; Endocardial electrodes piercing the pericardium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/3627—Heart stimulators for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
Definitions
- the present invention relates generally to invasive devices and methods for treatment of the heart, and specifically to devices and methods for improving cardiac performance.
- the human body normally regulates the cardiac output in response to body needs by changing the heart rate, as during physical exercise, and/or by adapting the stroke volume. Under pathological conditions, however, some of the normal regulatory mechanisms may be damaged. For example, heart tissue damaged due to myocardial infarct typically cannot sustain normal pumping function. Alternatively or additionally, physiological electrical signals are not generated, or are impaired in their propagation, and cardiac output or cardiac efficiency (stroke work divided by oxygen consumption) is correspondingly compromised. Standard pacemakers known in the art are able to control the rate of the heart, e.g., to accelerate the heart rate after detecting bradycardia, but are not able to increase contraction strength over the long-term without producing adverse side-effects.
- paired or coupled pacing pulses to the heart is known to produce a phenomenon called post-extrasystolic potentiation (PESP), in which the contraction force of the heart increases.
- PESP post-extrasystolic potentiation
- a paired pulse is an additional electric pulse applied to the heart a short time after an artificially-applied pacing pulse, for example, 300 ms thereafter.
- a coupled pacing pulse is similar, except that it is applied after a naturally- generated activation pulse.
- the term "paired pulse” refers generally to both paired and coupled pulses.
- US patent 5,391, 199 to Ben-Haim which is also incorporated herein by reference, describes a method and apparatus for ablating a portion of the heart to treat cardiac arrhythmias.
- a cardiac map is generated, and one or more catheters are advanced to sites adjacent to or within the heart. The location of each catheter's distal tip is determined, and local information about the heart is sensed at the distal tip of one or more of the catheters. The sensed information is processed to create one or more data points, which are superimposed on a perspective image of the heart to enable the targeted ablation of a portion of the heart.
- US patent 5,738,096 to Ben-Haim which is incorporated herein by reference, describes a method of constructing a cardiac map, in which a probe is brought into contact with a location on a wall of the heart. The probe's position is determined at at least two different phases of the heart cycle, and local electrical and non-electrical physiological values are determined at the location. The method is repeated for a plurality of locations in the heart, and the positions are combined to form a time- dependent map of at least a portion of the heart.
- an electrical cardiac stimulator for improving the performance of the heart of a human subject applies paired pulses to a plurality of ventricular sites in the heart.
- the sites include one or more sites in each of the left and right ventricles.
- the stimulator applies the pulses to a plurality of sites in one of the chambers of the heart, for example, in one of the atria or one of the ventricles.
- the stimulator comprises two or more electrodes, preferably placed at multiple sites in or on the heart, and a control unit.
- multi-site application of paired pulses induces a form of PESP which improves cardiac performance and, additionally, minimizes negative results associated with methods of PESP induction which are known in the art.
- multi-site paired pacing improves cardiac efficiency by increasing stroke work substantially without increasing oxygen consumption, typically reducing the incidence of heart failure associated with methods of pacing known in the art.
- the increase in stroke work is enabled, according to these embodiments, by coordinating the timing of cardiac muscle contraction, typically in patients who have abnormal interventricular and/or abnormal intraventricular action potential propagation and who therefore generally demonstrate inefficient cardiac contraction.
- the inventors further believe that by synchronizing the timing of the electrical activity at a plurality of sites in the heart, multi-site paired pacing decreases a likelihood of development of arrhythmia.
- the average stroke volume, responsive to repeated applications of paired pulses as described herein, is greater than that engendered responsive to either standard artificial pacing pulses or natural cardiac activity.
- use of these embodiments is appropriate, for example, for assisting a heart that is otherwise unable to satisfy immediate physiological requirements of flow rate, stroke volume, pumping efficiency, cardiac output or blood pressure.
- the electrodes are placed at multiple sites on the epicardium and/or endocardium of the stimulated ventricles, and, optionally, on other areas of the heart.
- one or more of the electrodes are inserted through a catheter into a coronary blood vessel and apply energy through the vessel wall to a selected area of the heart.
- each electrode conveys a particular waveform to the heart, which may differ in certain aspects from the waveforms applied to other electrodes.
- the particular waveform to be applied to each electrode is preferably determined by the control unit, initially under the control of a physician during a calibration period of the unit.
- the cardiac stimulator (or elements thereof) is implanted in the patient in a manner similar to that used to implant pacemakers or defibrillators known in the art. After the initial calibration period, the unit is generally able to automatically modify the waveforms as needed to maintain a desired level of performance of the stimulator. In many applications, standard pacing, cardioversion, and/or defibrillation capabilities are additionally incorporated into the stimulator.
- one or more mechanical sensors e.g., force transducers, strain gauges, pressure gauges, and/or motion sensors
- the control unit indicative of aspects of the heart's functioning.
- one or more physiological sensors e.g., for measuring blood pH, mixed venous oxygen saturation (SvO2) or thoracic electrical impedance, send physiological-sensor signals to the control unit.
- the various sensor signals serve as feedback to enable the control unit to iteratively adjust the paired pulses applied to one or both of the ventricles and to compare newly-measured signals with desired values.
- sensors such as sensing electrodes, blood pressure or flow sensors, are coupled to the heart or elsewhere on the patient's body, and send signals to the control unit which are used in determining modifications to parameters of the applied paired pulses.
- the control unit analyzes the sensor signals to detect an onset of arrhythmia, and modifies or terminates application of the paired pacing pulses responsive to the detection.
- a method for improving the performance of the heart of a human subject including: applying one or more paired pulses at a first ventricular site of the heart; and applying one or more paired pulses at a second ventricular site of the heart.
- the paired pulses are applied to at least the first site so as to induce post-extrasystolic potentiation.
- applying the paired pulses at the first and second ventricular sites includes applying paired pulses at sites on one ventricle of the heart.
- applying the paired pulses at the first ventricular site includes applying one or more pulses to one of the ventricles of the heart
- applying the paired pulses at the second ventricular site includes applying one or more pulses to the other ventricle of the heart.
- the paired pulses are applied to at least the first site so as to increase cardiac output.
- the paired pulses are applied to at least the first site so as to increase blood pressure generated by the heart.
- the paired pulses are applied to at least the first site so as to increase efficiency of the heart.
- the method includes: sensing activity of the heart to detect an arrhythmia thereof; and applying antiarrhythmic electrical energy to the heart to treat the arrhythmia.
- the paired pulses applied at the first site include: an artificially-applied pacing pulse; and a pulse applied at a designated interval following application of the pacing pulse.
- the method includes detecting a naturally- generated activation pulse.
- applying the one or more paired pulses at the first site includes applying at the first site a coupled pulse at a designated interval following the naturally-generated activation pulse.
- the first ventricular site is one of a plurality of test sites
- the method includes: applying paired pulses at each of the test sites during a calibration period; evaluating a response of the heart to the paired pulses applied during the calibration period, so as to determine one or more effective sites for subsequent application of the paired pulses; and applying paired pulses at the one or more effective sites responsive to the evaluation.
- the paired pulses are applied at at least one of the sites so as to reduce a potential for arrhythmia.
- the method includes: sensing activity of the heart to detect an arrhythmia thereof; and terminating application of the paired pulses to at least the first site responsive to the detection.
- detecting the arrhythmia includes detecting at least one ectopic heart beat.
- the method includes applying one or more pacing pulses at a pacing site of the heart.
- applying the paired pulses at the first site includes: applying one or more pacing pulses at the first site during a calibration period; evaluating at a plurality of detection sites a response of the heart to the one or more pacing pulses applied during the calibration period, so as to determine one or more effective sites for subsequent application of paired pulses; and during a regular operation period subsequent to the calibration period, applying at the first site one or more regular operation pacing pulses and applying at the one or more effective sites one or more pulses paired to the regular operation pacing pulses.
- the response of the heart includes a mechanical response or an electrical response.
- evaluating the response of the heart includes measuring the response later than about 50 ms subsequent to application of the pacing pulses. Further alternatively or additionally, evaluating the response of the heart includes measuring the response later than about 200 ms subsequent to application of the pacing pulses.
- the method includes sensing a physiological parameter of the subject and modifying responsive thereto a characteristic of the paired pulses applied to at least the first site.
- the parameter includes a mechanical or an electrical characteristic of the heart.
- the parameter includes blood pressure of the subject, the concentration of a gas in the blood of the subject, or blood pH.
- apparatus for improving the performance of the heart of a human subject including: a first ventricular electrode, coupled to a first ventricular site of the heart; a second ventricular electrode, coupled to a second ventricular site of the heart; and a control unit, which drives the first ventricular electrode to apply one or more paired pulses at the first ventricular site and drives the second ventricular electrode to apply one or more paired pulses at the second ventricular site.
- the apparatus includes a sensor, coupled to detect arrhythmia of the heart and to convey a signal responsive thereto to the control unit.
- the control unit applies antiarrhythmic energy to the heart to treat the arrhythmia.
- the control unit drives at least the first electrode to apply the pulses so as to increase efficiency of the heart.
- the paired pulses applied by at least the first electrode include: an artificially-applied pacing pulse; and a pulse applied at a designated " interval following application of the pacing pulse.
- control unit detects a naturally-generated activation pulse, and drives at least the first electrode to apply at the first site a coupled pulse, at a designated interval following the naturally-generated activation pulse.
- the first ventricular site is one of a plurality of test sites, and the first electrode is coupled in turn to each of the test sites during a calibration period.
- the control unit drives the first ventricular electrode to apply paired pulses at each of the test sites during the calibration period, and evaluates a response of the heart to the paired pulses applied during the calibration period to determine one or more effective sites for subsequent application of the paired pulses.
- the apparatus includes a pacing electrode, coupled to a pacing site of the heart, and the control unit drives the pacing electrode to apply pacing pulses to the pacing site.
- control unit drives at least one of the ventricular electrodes to apply the paired pulses so as to reduce a potential for arrhythmia.
- the apparatus includes a sensor, coupled to detect arrhythmia of the heart and to convey a signal responsive thereto to the control unit.
- the control unit terminates application of the paired pulses to at least one of the ventricular sites responsive to the signal.
- the arrhythmia includes at least one ectopic heart beat.
- the control unit drives the first ventricular electrode to apply one or more pacing pulses at the first site during a calibration period, and evaluates at a plurality of detection sites a response of the heart to the one or more pacing pulses applied during the calibration period, so as to determine one or more effective sites for subsequent application of paired pulses.
- the apparatus includes one or more paired-pulse electrodes, which are respectively coupled to the one or more effective sites responsive to the determination.
- the control unit drives the first ventricular electrode to apply at the first site one or more regular operation pacing pulses, and drives the one or more paired-pulse electrodes at the one or more effective sites to apply one or more pulses paired to the regular operation pacing pulses.
- the response of the heart includes a mechanical or an electrical response.
- the control unit measures the response later than about 50 ms subsequent to application of the pacing pulses.
- the apparatus includes at least one sensor coupled to the subject's body, which senses a physiological parameter of the subject and conveys to the control unit a sensor signal responsive thereto. Further preferably, the control unit modifies responsive to the sensor signal a characteristic of the paired pulses applied to at least one of the ventricular sites.
- the sensor is selected from the list consisting of: a motion sensor, an accelerometer, a strain gauge, a force transducer, an ECG sensor, a left ventricular pressure sensor, a blood pressure sensor, a thoracic electrical impedance sensor, an SvO2 sensor, a pH sensor, a pO2 sensor, a pCO2 sensor, an electrical activity sensor, and a blood flow rate sensor.
- a method for improving the performance of the heart of a human subject including: applying one or more paired pulses at a first site of a chamber of the heart; and applying one or more paired pulses at a second site of the chamber.
- the first site is one of a plurality of test sites
- the method includes: applying paired pulses at each of the test sites during a calibration period; evaluating a response of the heart to the paired pulses applied during the calibration period to determine one or more effective sites for subsequent application of the paired pulses; and applying paired pulses at the one or more effective sites responsive to the evaluation.
- applying the paired pulses at the first site includes: applying one or more pacing pulses at the first site during a calibration period; evaluating at a plurality of detection sites a response of the heart to the one or more pacing pulses applied during the calibration period, so as to determine one or more effective sites for subsequent application of paired pulses; and during a regular operation period subsequent to the calibration period, applying at the first site one or more regular operation pacing pulses and applying at the one or more effective sites one or more pulses paired to the regular operation pacing pulses.
- apparatus for improving the performance of the heart of a human subject including: a first electrode, coupled to a first site of a chamber of the heart; a second electrode, coupled to a second site of the chamber; and a control unit, which drives the first electrode to apply one or more paired pulses at the first site and drives the second electrode to apply one or more paired pulses at the second site.
- apparatus for improving the performance of the heart of a human subject using a first ventricular electrode and a second ventricular electrode, coupled respectively to a first ventricular site and a second ventricular site of the heart including a control unit, which drives the first ventricular electrode to apply one or more paired pulses at the first ventricular site and drives the second ventricular electrode to apply one or more paired pulses at the second ventricular site.
- apparatus for improving the performance of the heart of a human subject using a first electrode, coupled to a first site of a chamber of the heart, and a second electrode, coupled to a second site of the chamber including a control unit, which drives the first electrode to apply one or more paired pulses at the first site and drives the second electrode to apply one or more paired pulses at the second site.
- Fig. 1 is a schematic illustration of the external surface of a heart, showing the placement of electrodes and sensors thereon, in accordance with a preferred embodiment of the present invention.
- Fig. 2 is a schematic block diagram of a control unit, which generates signals to be applied to the electrodes shown in Fig. 1, in accordance with a preferred embodiment of the present invention.
- Fig. 1 is a schematic illustration of cardiac control apparatus 18, which applies electrical energy to improve the performance of the heart 20 of a patient, in accordance with a preferred embodiment of the present invention.
- Apparatus 18 preferably comprises an implantable or external control unit 90, which applies paired pulses through multiple electrodes 100, comprising one or more electrodes 32, electrically coupled to the right ventricle 30, and/or to one or more electrodes 34, electrically coupled to the left ventricle 44 of heart 20.
- paired pulses are applied to the right and/or left atria 28 and 29 through respective electrodes 36 and 38 coupled to the control unit. (As defined in the Background section, the term "paired pulse” refers herein generally to both paired and coupled pulses.)
- the average stroke volume of cardiac muscle tissue exposed to repeated applications of the paired pulses is greater than that generated responsive to either standard artificial pacing pulses or natural cardiac activity.
- use of this embodiment is appropriate, for example, for assisting a heart that is otherwise unable to satisfy immediate physiological requirements of cardiac output or blood pressure.
- Electrodes 100 are typically coupled to epicardium 50 overlying the ventricles. Electrodes 100 may also be coupled to the endocardium or to other suitable locations in or on the patient's body. In some applications, it is desirable to insert one or more of electrodes 100 into a blood vessel in a vicinity of ventricle 30 or 44.
- Control unit 90 is also optionally coupled to one or more local sense electrodes 74, which are placed on or in the heart and convey electrical signals responsive to cardiac electric activity. Alternatively or additionally, one or more of electrodes 100 and any of the other electrodes coupled to control unit 90 may also serve as sense electrodes.
- one or more mechanical sensors 70 e.g., accelerometers, force transducers, strain gauges, or pressure gauges
- one or more supplemental sensors 72 e.g., blood pressure, thoracic electrical impedance, SvO2, pH, pCO2 or pO2 sensors
- supplemental sensors 72 are coupled to the control unit and are placed on or in the heart or elsewhere on or in the patient's body.
- control unit 90 modifies the energy applied through electrodes 100, 36 and/or 38 responsive to signals from sensors 70 and 72 and local sense electrodes 74, as described hereinbelow.
- control unit 90 and the above-mentioned electrodes and sensors are permanently or semi- permanently implanted in or coupled to the patient's body. (For clarity, connections between control unit 90 and only some of the electrodes and sensors are shown in Fig.
- Electrodes and sensors are shown in Fig. 1 by way of example. Other sites on heart 20 or in a vicinity thereof are appropriate for electrode and sensor placement in other applications of the present invention.
- Different types of electrodes known in the art are typically selected based on the specific condition of the patient's heart, and may comprise coil, defibrillation, screw, patch, basket, needle and/or wire electrodes, or substantially any other electrode known in the art of electrical stimulation or sensing in tissue.
- an electrode is passed through the coronary sinus and positioned so as to stimulate the left ventricle or another chamber of the heart.
- one or more of the electrodes are placed during an endoscopic procedure or during open chest surgery.
- control unit 90 is implanted in the patient in a manner similar to that used to implant pacemakers or defibrillators known in the art, such that after an initial calibration period, described hereinbelow, the unit is generally able to automatically modify the pulses it applies to the heart as needed to maintain a desired level of performance.
- pacing, cardioversion, and defibrillation capabilities are additionally incorporated into apparatus 18.
- Fig. 2 is a schematic block diagram of control unit 90, in accordance with a preferred embodiment of the present invention.
- Mechanical sensors 70, supplemental sensors 72, local sense electrodes 74, and electrodes 100 are preferably coupled to provide feedback signals to a cardiac function analysis block 80 of control unit 90.
- the feedback signals generally provide information about various aspects of the heart's performance to block 80, which analyzes the signals and actuates control unit 90 to modify the electrical energy applied to the heart responsive to the analysis.
- the paired pulses are adjusted by the control unit responsive to the feedback signals in order to yield a desired response, e.g., a predetermined blood pressure, blood oxygen level, cardiac output and/or cardiac electrical or motion profile. It will be understood that the arrangement of inputs to the control unit as shown in Fig.
- Electrodes 36 and/or 38 are coupled to the control unit, in parallel with or instead of electrodes 100.
- block 80 conveys results of its analysis to a "parameter search and tuning" block 84 of control unit 90, which iteratively modifies characteristics of the electrical signals applied to the heart in order to attain a desired response.
- operating parameters of block 84 are entered by a human operator of the control unit using operator controls 71, which typically comprise a keyboard or mouse (not shown) coupled to the control unit.
- Operator controls 71 typically comprise a keyboard or mouse (not shown) coupled to the control unit.
- Block 84 typically utilizes multivariate optimization and control methods known in the art in order to cause one or more of the aforementioned mechanical, electrical, chemical and/or other measured parameters to converge to desired values.
- each one of electrodes 100 may convey a particular waveform to heart 20, differing in certain aspects from the waveforms applied by the other electrodes.
- the particular waveform to be applied by each electrode is determined by control unit 90, preferably under the control of the operator.
- Aspects of the waveforms which are set by the control unit, and may differ from electrode to electrode typically include parameters such as time shifts between application of waveforms at different electrodes, waveform shapes, amplitudes, DC offsets, durations, and duty cycles.
- the waveforms applied to some or all of electrodes 100 usually comprise a monophasic square wave pulse following a natural or applied pacing pulse
- other waveforms such as a sinusoid, a series of biphasic square waves, or a waveform including an exponentially-varying characteristic, could be applied to other electrodes.
- shape, magnitude, and timing of the waveforms are optimized for each patient, using suitable optimization algorithms as are known in the art.
- block 84 typically modifies a set of controllable parameters of the paired pulses, responsive to the measured parameters, in accordance with values in a look-up table and/or preprogrammed formulae stored in an electronic memory of control unit 90.
- the controllable parameters may comprise, for example, pulse timing, magnitude, offset, and monophasic or biphasic shape.
- the controllable parameters are conveyed by block 84 to a signal generation block 86 of control unit 90, which generates, responsive to the parameters, electrical signals that are applied by electrodes 100 to ventricles 30 and 44.
- Block 86 preferably comprises amplifiers, isolation units, and other standard circuitry known in the art of electrical signal generation.
- parameter search and tuning block 84 preferably modifies a characteristic (e.g., timing, magnitude, and/or shape) of the paired pulses applied through one of electrodes 100, 36 and/or 38, and then determines whether a predetermined cardiac functional response generally improves following the modification.
- block 84 repeatedly modifies characteristics of the signals applied through each of the electrodes, such that those modifications that improve the response are generally maintained, and modifications that cause it to worsen are typically eliminated or avoided.
- the calibration procedure is subsequently performed by a physician at intermittent follow-up visits, and/or by unit 90 automatically during regular use of the apparatus (e.g., daily).
- apparatus 18 is calibrated in the presence of a physician, it is often desirable to have the patient perform increasing levels of exercise
- the calibration procedure comprises the application of standard (non-paired) pacing pulses at some sites, in conjunction with the application of paired pulses at other sites, so as to determine, by means of standard optimization methods known in the art, (a) a first set of sites, in one or more of the chambers of heart 20, in which standard pacing pulses improve the cardiac functional response, and (b) an additional set of sites, in one or more of the chambers, in which paired pacing pulses improve the response, particularly when applied in conjunction with the standard pacing pulses.
- the procedure additionally comprises determining a schedule for the application of paired and standard pacing pulses at the various sites during regular operation.
- a left ventricular site may exclusively be stimulated by paired pacing pulses
- a right ventricular site only by standard pacing pulses
- a right atrial site may alternate between paired and standard pulses, according to the schedule generated during the calibration procedure.
- the locations of one or more of electrodes 100, 36, and/or 38 are varied while signals are applied therethrough, so as to determine optimum placement of the electrodes.
- the physician may initially place one of electrodes 32 on epicardium 50 of right ventricle 30, and determine the electrical and/or mechanical response of heart 20.
- methods for measuring the heart's response include electrocardiography, echocardiography, and/or methods having as inputs the outputs of mechanical and supplemental sensors 70 and 72.
- the electrode is moved over an area of the right ventricle, and the response of the heart is measured.
- the electrode is returned to the site yielding the best response. Subsequently, other electrodes placed on, in, or near the right ventricle or other chambers of the heart are moved according to the same protocol, so as to achieve substantially optimum placement of some or all of the electrodes.
- pacing pulses are applied at a first site during the calibration period, and an electrical and/or mechanical cardiac functional response to the pacing pulse is measured at a plurality of detection sites.
- the measurements enable a determination of which of the detection sites generate the response excessively late with respect to the pacing pulse, e.g., later than approximately 200 ms following the pacing pulse, or, alternatively, later than only 50 ms following the pacing pulse.
- electrodes are placed at one or more of the detection sites showing such late activity, such that during regular operation, paired pulses may be applied at each of these detection sites. It will be appreciated that the calibration and other procedures described herein are typically applicable to any one or more of the heart's chambers.
- the initial calibration procedure comprises an evaluation of data taken prior to the placement of electrodes 100, 36, and/or 38 in a vicinity of heart 20.
- the initial calibration procedure includes an evaluation of ECG data to determine the nature and locations of a pathology to be treated or compensated for, by application of an embodiment of the invention.
- data generated using techniques described in the above-referenced US patents 5,391, 199 ('199) and 5,738,096 ('096) are utilized in selecting appropriate electrode sites and/or pulse application protocols. These techniques may be used to detect action potential propagation abnormalities (e.g., reduced action potential propagation speed) in one or more of the heart's chambers.
- action potential propagation abnormalities e.g., reduced action potential propagation speed
- the cardiac dysfunction is typically observed via an electrical and/or mechanical activation map which is generated using techniques described in the '199 and/or '096 patents.
- the electrical activation map shows at least one site whose electrical activation is later than, for example, 50 ms or 70 ms subsequent to a first detected ventricular activation, and an electrode is placed at that site and/or at one or more sites on the map demonstrating the greatest delays in activation.
- the mechanical activation map may be analyzed to determine suitable sites for electrode placement.
- a mechanical characteristic such as muscle thickness or local contraction strength is assessed in combination with the electrical activation map when deciding electrode placement locations.
- two sites which each show a delay of 70 ms, may differ mechanically such that only one of the sites is selected to have an electrode coupled thereto.
- electrodes are coupled to the heart to apply paired pulses, as described hereinabove, in such a manner as to minimize or eliminate an observed dysfunction and restore normal contraction.
- an analysis of ECG data and/or of data obtained via applying the techniques of the '199 or the '096 patents is used to define an initial electrode placement and paired-pulse application strategy, and this is subsequently refined using some of the other calibration techniques described hereinabove.
- an arrhythmia detection block 82 of control unit 90 receives inputs from sensors 70 and 72 and electrodes 74 and 100, and/or other electrodes and sensors (not shown), and evaluates these inputs to detect an onset of cardiac arrhythmia, e.g., an ectopic heartbeat, fibrillation, bradycardia or heart block.
- block 82 employs techniques known in the art for detecting arrhythmias, so that parameter search and tuning block 84 can treat or terminate the arrhythmia by applying, for example, regular pacing pulses or defibrillation pulses, and/or by discontinuing application of the paired pulses.
- Detection block 82 preferably analyzes the outputs of the various electrodes and sensors with respect to the two parameter sets, and applies paired pulses only after determining that substantially no ectopic behavior is present.
- application of the paired pulses is accompanied by artificial pacing pulses, which are preferably applied to electrodes 100 before application of the paired pulses thereto.
- one of the ventricles may be stimulated with a standard pacing pulse and subsequently with a paired pulse.
- the other ventricle may also be stimulated with artificial pacing pulses and paired pulses, or, alternatively, with pulses coupled to naturally-generated pacing pulses.
- the sinoatrial node generates the cardiac rhythm, substantially without artificial pacing.
- local sense electrodes 74 and, optionally, some or all of electrodes 100 convey electrical signals to control unit 90, so as to enable parameter search and tuning block 84 to synchronize the electrical signals applied by electrodes 100 with the natural electrical activity of the heart. Responsive to the detected electrical activity, artificial pulses coupled in time to the natural pulses are applied to one or both ventricles.
- electrodes 74 and 100 are shown for clarity of explanation as separate entities, a single set of electrodes may be used to perform both functions.
- one of the ventricles is stimulated at multiple sites, while the other ventricle is substantially not artificially stimulated at all. In other modes, each ventricle is stimulated at one or more locations thereof.
- the paired pulses have generally the same magnitude and shape as pacing signals known in the art.
- the time interval between a first pulse (natural or artificial) and a second pulse which is paired to the first pulse is approximately 80-400 ms, typically between about 100 and 200 ms.
- the first pulse is applied at all designated ventricular sites substantially simultaneously.
- both ventricles are paced, and an interventricular delay typically not exceeding 50-100 ms is set between a pacing pulse applied in one of the ventricles and a pacing pulse applied in the other ventricle.
- the delay is determined during the initial calibration procedure. In other embodiments, the timing of .
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU32190/01A AU3219001A (en) | 2000-02-09 | 2001-02-01 | Cardiac control using paired pacing |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50156200A | 2000-02-09 | 2000-02-09 | |
US09/501,562 | 2000-02-09 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2001058518A2 true WO2001058518A2 (en) | 2001-08-16 |
WO2001058518A3 WO2001058518A3 (en) | 2002-01-17 |
WO2001058518A8 WO2001058518A8 (en) | 2002-05-23 |
Family
ID=23994071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2001/000098 WO2001058518A2 (en) | 2000-02-09 | 2001-02-01 | Cardiac control using paired pacing |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3219001A (en) |
WO (1) | WO2001058518A2 (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004078257A1 (en) * | 2003-02-28 | 2004-09-16 | Medtronic Inc. | Method and appartus for optimizing cardiac resynchronization therapy based on left ventricular acceleration |
US7096064B2 (en) | 2001-08-28 | 2006-08-22 | Medtronic, Inc. | Implantable medical device for treating cardiac mechanical dysfunction by electrical stimulation |
US7142916B2 (en) | 2003-10-07 | 2006-11-28 | Medtronic, Inc. | Cardiac pacing modality having improved blanking, timing, and therapy delivery methods for extra-systolic stimulation pacing therapy |
US7233824B2 (en) | 2003-10-07 | 2007-06-19 | Medtronic, Inc. | Secure and efficacious therapy delivery for an extra-systolic stimulation pacing engine |
WO2007075321A1 (en) | 2005-12-22 | 2007-07-05 | Cardiac Pacemakers, Inc. | Method and apparatus for improving cardiac efficiency based on myocardial oxygen consumption |
WO2007090031A1 (en) * | 2006-01-30 | 2007-08-09 | Medtronic, Inc. | Method and system for controlling pulmonary capillary pressure |
WO2009042140A1 (en) * | 2007-09-25 | 2009-04-02 | Cardiac Pacemakers, Inc. | Closed-loop control of intermittent excitatory cardiac stimulation for therapeutic effect |
US7751888B1 (en) | 2006-08-28 | 2010-07-06 | Pacesetter, Inc. | Systems and methods for delivering stimulation pulses using an implantable cardiac stimulation device |
US7970466B2 (en) | 2003-10-07 | 2011-06-28 | Medtronic, Inc. | Method and apparatus for optimization and assessment of response to extra-systolic stimulation (ESS) therapy |
US8620424B2 (en) | 2007-04-30 | 2013-12-31 | Medtronic, Inc. | Method and apparatus for providing extra systolic stimulation |
US8706224B1 (en) | 2007-10-30 | 2014-04-22 | Pacesetter, In. | Systems and methods for paired/coupled pacing and dynamic overdrive/underdrive pacing |
US8768461B2 (en) | 2011-09-06 | 2014-07-01 | Pacesetter, Inc. | Systems and methods for controlling paired pacing interpulse intervals to reduce contractility disequilibrium using an implantable medical device |
US8818510B2 (en) | 2007-10-30 | 2014-08-26 | Pacesetter, Inc. | Systems and methods for paired/coupled pacing |
US8886306B2 (en) | 2008-08-20 | 2014-11-11 | Cardiac Pacemakers, Inc. | Triggered high-output pacing therapy |
US10166396B2 (en) | 2015-04-24 | 2019-01-01 | Medtronic, Inc. | Efficient delivery of multi-site pacing |
US10694967B2 (en) | 2017-10-18 | 2020-06-30 | Medtronic, Inc. | State-based atrial event detection |
US11013925B2 (en) | 2015-07-16 | 2021-05-25 | Medtronic, Inc. | Confirming sensed atrial events for pacing during resynchronization therapy in a cardiac medical device and medical device system |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5213098A (en) * | 1991-07-26 | 1993-05-25 | Medtronic, Inc. | Post-extrasystolic potentiation stimulation with physiologic sensor feedback |
US5792208A (en) * | 1991-05-17 | 1998-08-11 | Gray; Noel Domond | Heart pacemaker |
-
2001
- 2001-02-01 AU AU32190/01A patent/AU3219001A/en not_active Abandoned
- 2001-02-01 WO PCT/IL2001/000098 patent/WO2001058518A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5792208A (en) * | 1991-05-17 | 1998-08-11 | Gray; Noel Domond | Heart pacemaker |
US5213098A (en) * | 1991-07-26 | 1993-05-25 | Medtronic, Inc. | Post-extrasystolic potentiation stimulation with physiologic sensor feedback |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7096064B2 (en) | 2001-08-28 | 2006-08-22 | Medtronic, Inc. | Implantable medical device for treating cardiac mechanical dysfunction by electrical stimulation |
US6885889B2 (en) | 2003-02-28 | 2005-04-26 | Medtronic, Inc. | Method and apparatus for optimizing cardiac resynchronization therapy based on left ventricular acceleration |
WO2004078257A1 (en) * | 2003-02-28 | 2004-09-16 | Medtronic Inc. | Method and appartus for optimizing cardiac resynchronization therapy based on left ventricular acceleration |
US7970466B2 (en) | 2003-10-07 | 2011-06-28 | Medtronic, Inc. | Method and apparatus for optimization and assessment of response to extra-systolic stimulation (ESS) therapy |
US7142916B2 (en) | 2003-10-07 | 2006-11-28 | Medtronic, Inc. | Cardiac pacing modality having improved blanking, timing, and therapy delivery methods for extra-systolic stimulation pacing therapy |
US7233824B2 (en) | 2003-10-07 | 2007-06-19 | Medtronic, Inc. | Secure and efficacious therapy delivery for an extra-systolic stimulation pacing engine |
US9101772B2 (en) | 2003-10-07 | 2015-08-11 | Medtronic, Inc. | Secure and efficacious therapy delivery for a pacing engine |
WO2007075321A1 (en) | 2005-12-22 | 2007-07-05 | Cardiac Pacemakers, Inc. | Method and apparatus for improving cardiac efficiency based on myocardial oxygen consumption |
US9155896B2 (en) | 2005-12-22 | 2015-10-13 | Cardiac Pacemakers, Inc. | Method and apparatus for improving cardiac efficiency based on myocardial oxygen consumption |
JP2009521263A (en) * | 2005-12-22 | 2009-06-04 | カーディアック ペースメイカーズ, インコーポレイテッド | Method and apparatus for improving cardiac efficiency based on myocardial oxygen consumption |
WO2007090031A1 (en) * | 2006-01-30 | 2007-08-09 | Medtronic, Inc. | Method and system for controlling pulmonary capillary pressure |
US9149638B2 (en) * | 2006-01-30 | 2015-10-06 | Medtronic, Inc. | Method and system for controlling pulmonary capillary pressure |
US7751888B1 (en) | 2006-08-28 | 2010-07-06 | Pacesetter, Inc. | Systems and methods for delivering stimulation pulses using an implantable cardiac stimulation device |
US8620424B2 (en) | 2007-04-30 | 2013-12-31 | Medtronic, Inc. | Method and apparatus for providing extra systolic stimulation |
US8131363B2 (en) | 2007-09-25 | 2012-03-06 | Cardiac Pacemakers, Inc. | Closed-loop control of intermittent excitatory cardiac stimulation for therapeutic effect |
US8588907B2 (en) | 2007-09-25 | 2013-11-19 | Cardiac Pacemakers, Inc. | Closed-loop control of intermittent excitatory cardiac stimulation for therapeutic effect |
JP2010540076A (en) * | 2007-09-25 | 2010-12-24 | カーディアック ペースメイカーズ, インコーポレイテッド | Closed loop control of intermittent excitatory cardiac stimulation for therapeutic effects |
WO2009042140A1 (en) * | 2007-09-25 | 2009-04-02 | Cardiac Pacemakers, Inc. | Closed-loop control of intermittent excitatory cardiac stimulation for therapeutic effect |
US8706224B1 (en) | 2007-10-30 | 2014-04-22 | Pacesetter, In. | Systems and methods for paired/coupled pacing and dynamic overdrive/underdrive pacing |
US8818510B2 (en) | 2007-10-30 | 2014-08-26 | Pacesetter, Inc. | Systems and methods for paired/coupled pacing |
US8886306B2 (en) | 2008-08-20 | 2014-11-11 | Cardiac Pacemakers, Inc. | Triggered high-output pacing therapy |
US8768461B2 (en) | 2011-09-06 | 2014-07-01 | Pacesetter, Inc. | Systems and methods for controlling paired pacing interpulse intervals to reduce contractility disequilibrium using an implantable medical device |
US10166396B2 (en) | 2015-04-24 | 2019-01-01 | Medtronic, Inc. | Efficient delivery of multi-site pacing |
US10646717B2 (en) | 2015-04-24 | 2020-05-12 | Medtronic, Inc. | Efficient delivery of multi-site pacing |
US11013925B2 (en) | 2015-07-16 | 2021-05-25 | Medtronic, Inc. | Confirming sensed atrial events for pacing during resynchronization therapy in a cardiac medical device and medical device system |
US10694967B2 (en) | 2017-10-18 | 2020-06-30 | Medtronic, Inc. | State-based atrial event detection |
Also Published As
Publication number | Publication date |
---|---|
WO2001058518A3 (en) | 2002-01-17 |
AU3219001A (en) | 2001-08-20 |
WO2001058518A8 (en) | 2002-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1284781B1 (en) | Signal delivery through the right ventricular septum | |
US9713723B2 (en) | Signal delivery through the right ventricular septum | |
EP1079893B1 (en) | Cardiac pacing using adjustable atrio-ventricular delays | |
US7769451B2 (en) | Method and apparatus for optimizing cardiac resynchronization therapy | |
US7184835B2 (en) | Method and apparatus for adjustable AVD programming using a table | |
JP5226789B2 (en) | Method, apparatus and system for optimizing cardiac preload based on measured pulmonary artery pressure | |
US9272147B2 (en) | Method and apparatus to deliver mechanically fused pacing therapy | |
JP5183467B2 (en) | Cardiac therapy control system based on electromechanical timing | |
US6285906B1 (en) | Muscle contraction assist device | |
JP5256197B2 (en) | Heart treatment system | |
US6587721B1 (en) | Trigger-based regulation of excitable tissue control of the heart | |
WO2018017361A1 (en) | Method and system for determining pace timing in a leadless cardiac pacemaker system | |
WO2001058518A2 (en) | Cardiac control using paired pacing | |
US8483826B2 (en) | Deactivation of intermittent pacing therapy | |
US9604063B2 (en) | Method, apparatus and system to identify optimal pacing parameters using sensor data | |
US20080147138A1 (en) | Cardiac stimulation device for sinus rate modulation | |
US20170291022A1 (en) | Multi-site crt capture verification | |
US20110087301A1 (en) | Implantable device with hemodynamic support or resuscitation therapy | |
US8825156B2 (en) | System and method for decompensation detection and treatment based on patient hemodynamics | |
IL129257A (en) | Trigger-based regulation of excitable tissue control in the heart |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WR | Later publication of a revised version of an international search report | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase in: |
Ref country code: JP |